Lilly Ventures logo

Lilly Ventures

North America, Indiana, United States, Indianapolis

Description

Lilly Ventures is an Indiana-based venture capital firm that provides investment to companies in the life sciences sector.

Investor Profile

Lilly Ventures has made 69 investments, with 0 in the past 12 months and 26% as lead.

Stage Focus

  • Series C (28%)
  • Series B (23%)
  • Series A (19%)
  • Series D (13%)
  • Series E (7%)
  • Series Unknown (3%)
  • Seed (3%)
  • Private Equity (1%)
  • Debt Financing (1%)
  • Convertible Note (1%)

Country Focus

  • United States (91%)
  • Australia (4%)
  • Israel (3%)
  • United Kingdom (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Biopharma
  • Oncology
  • Life Science
  • Medical Device
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Lilly Ventures frequently co-invest with?

Amgen Ventures
North America, California, United States, San Francisco
Co-Investments: 8
Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 6
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 14
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 8
Intersouth Partners
North America, North Carolina, United States, Durham
Co-Investments: 5
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 10
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 5
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 9
Roche Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 7
Venrock
North America, California, United States, Palo Alto
Co-Investments: 7

Which angels does Lilly Ventures often collaborate with?

HT
Europe, Noord-Brabant, The Netherlands, Tilburg
Shared Deals: 1
BG
North America, Washington, United States, Seattle
Shared Deals: 3
PS
North America, California, United States, San Mateo
Shared Deals: 1
ES
North America, New Jersey, United States, Princeton
Shared Deals: 1

What are some of recent deals done by Lilly Ventures?

BioAge Labs

Richmond, California, United States

BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.

BiopharmaBiotechnologyLife ScienceTherapeutics
Series DFeb 13, 2024
Amount Raised: $170,000,000
IpiNovyx Bio

West Nyack, New York, United States

IpiNovyx Bio is a biopharmaceutical company developing immunoproteasome-modulating therapeutics to treat autoimmune diseases.

BiopharmaBiotechnologyHealth CareMedical
SeedOct 5, 2021
Amount Raised: $10,000,000
Evox Therapeutics

Oxford, Oxfordshire, United Kingdom

Evox Therapeutics is a biotechnology company that harnesses and engineer the natural trafficking capabilities of extracellular vesicles.

BiotechnologyHealth CarePharmaceutical
Convertible NoteJun 9, 2020
Amount Raised: $10,000,000
Kymera Therapeutics

Cambridge, Massachusetts, United States

Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.

BiotechnologyHealth CareMedicalTherapeutics
Series BNov 13, 2018
Amount Raised: $65,000,000
Sutro Biopharma

South San Francisco, California, United States

Sutro Biopharma develops protein therapeutics by using OCFS protein synthesis technology.

BiotechnologyInformation TechnologyMedical
Series EJul 26, 2018
Amount Raised: $85,400,000
Nimbus Therapeutics

Boston, Massachusetts, United States

Nimbus Therapeutics uses computational technology to create selective small molecule therapeutics.

BiotechnologyHealth CareTherapeutics
Series CJun 5, 2018
Amount Raised: $65,000,000
Kymera Therapeutics

Cambridge, Massachusetts, United States

Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.

BiotechnologyHealth CareMedicalTherapeutics
Series AOct 30, 2017
Amount Raised: $30,000,000
Cavion

Charlottesville, Virginia, United States

Cavion is a clinical stage pharmaceutical company committed to providing patients with therapies.

BiotechnologyHealth CarePharmaceutical
Series AJan 6, 2017
Amount Raised: $26,100,000
Protagonist Therapeutics

Brisbane, Queensland, Australia

Protagonist Therapeutics develops orally-stable peptides to treat diseases that are currently addressed by injectable antibodies.

BiotechnologyHealth CareMedical
Series CJul 16, 2015
Amount Raised: $40,000,000
Aeglea BioTherapeutics

Austin, Texas, United States

Aeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases.

BiotechnologyHealth CareTherapeutics
Series BMar 23, 2015
Amount Raised: $44,000,000